NCT05116748View on ClinicalTrials.gov

COVID19 Vaccine in SOT Adult Recipients

CompletedOBSERVATIONAL
Enrollment

364

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 30, 2022

Study Completion Date

December 31, 2023

Conditions
COVID-19Vaccine Adverse ReactionVaccine Response ImpairedVaccine ReactionLung Transplant; ComplicationsLiver Transplant; ComplicationsVaccination
Interventions
BIOLOGICAL

COVID19 mRNA vaccine

Administration of COVID19 mRNA vaccine

Trial Locations (1)

20122

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan

All Listed Sponsors
lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

NCT05116748 - COVID19 Vaccine in SOT Adult Recipients | Biotech Hunter | Biotech Hunter